Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population

作者：Francesco Vitiello, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, Changhoon Yoo, Sara Lonardi, Francesco Tovoli, Takashi Kumada, Mario Scartozzi, Emiliano Tamburini, Francesco Giuseppe Foschi, Mara Persano, Federico Rossari, Silvia Foti, Silvia Camera, Francesco De Cobelli, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei‐Gardini, Margherita Rimini · 发表于：Seminars in Oncology · 年份：2025 · DOI：10.1016/j.seminoncol.2025.152348 · 被引用次数：2 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Cholangiocarcinoma and Gallbladder Cancer Studies、Colorectal Cancer Treatments and Studies